Transforming Growth Factor beta3
"Transforming Growth Factor beta3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A TGF-beta subtype that plays role in regulating epithelial-mesenchymal interaction during embryonic development. It is synthesized as a precursor molecule that is cleaved to form mature TGF-beta3 and TGF-beta3 latency-associated peptide. The association of the cleavage products results in the formation a latent protein which must be activated to bind its receptor.
Descriptor ID |
D053782
|
MeSH Number(s) |
D12.644.276.374.687.300 D12.644.276.954.775.300 D12.776.467.374.687.300 D12.776.467.942.775.300 D23.529.942.775.300
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Transforming Growth Factor beta3".
Below are MeSH descriptors whose meaning is more specific than "Transforming Growth Factor beta3".
This graph shows the total number of publications written about "Transforming Growth Factor beta3" by people in this website by year, and whether "Transforming Growth Factor beta3" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transforming Growth Factor beta3" by people in Profiles.
-
Huang H, Veien ES, Zhang H, Ayers DC, Song J. Skeletal Characterization of Smurf2-Deficient Mice and In Vitro Analysis of Smurf2-Deficient Chondrocytes. PLoS One. 2016; 11(1):e0148088.
-
Yang CS, Lopez CG, Rana TM. Discovery of nonsteroidal anti-inflammatory drug and anticancer drug enhancing reprogramming and induced pluripotent stem cell generation. Stem Cells. 2011 Oct; 29(10):1528-36.